Cancer
RNF43 721-729 mutant (HLA-A*24:02) 272Y NYQPVWLCL
Product number: EP11414_5
€210.00*
Prices excl. VAT plus shipping
costs
Available, delivery time:
3 weeks
sterile and endotoxin free
Delivery Format: The product is supplied freeze dried.
Purity:
95% HPLC-MS
Caution:
For research use only. Not for use in humans.
Amount in mg
1
Description
This peptide has a high avidity for CD8 T cells, and can be used in the analysis of individual antigen-specific T cells. This product is a MHC pentamer of peptide composed RNF43 (722Y)-derived peptide of NYQPVWLCL sequence covering 721-729 and A*24:02 molecule.
TechData
| Sequence: | NYQPVWLCL |
| Gene: | RNF43 |
| Delivery: | 3 weeks |
| C-Terminus: | OH |
| N-Terminus: | H |
| Amount: | 1 mg |
| Counterion: | TFA |
| Protein: | RING-type E3 ubiquitin transferase RNF43 |
| Species: | Human |
| Allele: | HLA-A*24:02 |
| Application: | Flow Cytometry |
| Indication: | Cancer |
| Purity: | 95% HPLC-MS |